International Standard Serial Number (ISSN)
publication venue for
Eradication of LIG4-deficient glioblastoma cells by the combination of PARP inhibitor and alkylating agent.
V-ATPase-dependent repression of androgen receptor in prostate cancer cells.
Silencing ROR1 and ROR2 inhibits invasion and adhesion in an organotypic model of ovarian cancer metastasis.
Methionine restriction on oxidative stress and immune response in dss-induced colitis mice.
S-nitrosation on zinc finger motif of PARP-1 as a mechanism of DNA repair inhibition by arsenite.
The degree of intratumor mutational heterogeneity varies by primary tumor sub-site.
----Cyclic AMP efflux inhibitors as potential therapeutic agents for leukemia.
A targeted genetic association study of epithelial ovarian cancer susceptibility.
Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion.
Targeted or whole genome sequencing of formalin fixed tissue samples: potential applications in cancer genomics.
Anti-G-CSF treatment induces protective tumor immunity in mouse colon cancer by promoting protective NK cell, macrophage and T cell responses.
Targeting of mutant p53-induced FoxM1 with thiostrepton induces cytotoxicity and enhances carboplatin sensitivity in cancer cells.